Your browser is no longer supported. Please, upgrade your browser.
AUPH Aurinia Pharmaceuticals Inc. daily Stock Chart
Aurinia Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.76 Insider Own- Shs Outstand85.34M Perf Week-3.81%
Market Cap538.51M Forward P/E- EPS next Y-0.55 Insider Trans- Shs Float67.76M Perf Month-7.61%
Income- PEG- EPS next Q-0.15 Inst Own- Short Float8.84% Perf Quarter-15.19%
Sales0.46M P/S1163.10 EPS this Y-54.50% Inst Trans- Short Ratio6.70 Perf Half Y6.05%
Book/sh1.32 P/B4.79 EPS next Y46.10% ROA- Target Price11.92 Perf Year12.88%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range5.06 - 7.85 Perf YTD-7.48%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-19.62% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low24.70% ATR0.23
Employees39 Current Ratio- Sales Q/Q-3.30% Oper. Margin- RSI (14)44.61 Volatility3.40% 3.61%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.49 Prev Close6.32
ShortableYes LT Debt/Eq- EarningsMar 19 AMC Payout- Avg Volume894.20K Price6.31
Recom1.70 SMA20-3.23% SMA50-3.04% SMA2004.65% Volume438,606 Change-0.16%
Mar-16-18Reiterated Cantor Fitzgerald Overweight $14 → $16
Feb-08-18Initiated RBC Capital Mkts Outperform $9
Oct-30-17Reiterated H.C. Wainwright Buy $10 → $12
May-18-17Reiterated H.C. Wainwright Buy $12 → $10
Apr-11-17Initiated Cantor Fitzgerald Overweight $14
Mar-22-17Reiterated FBR & Co. Outperform $9 → $11
Dec-30-16Reiterated H.C. Wainwright Buy $10 → $8
Aug-17-16Reiterated H.C. Wainwright Buy $7 → $10
Jun-30-16Initiated H.C. Wainwright Buy $7
May-08-15Initiated MLV & Co Buy $9
Apr-11-19 04:30PM  Aurinia Announces Appointment of Peter Greenleaf as Chief Executive Officer and Board Director and the Elevation of Dr. George M. Milne, Jr. to Chairman of the Board Business Wire
Apr-10-19 08:46AM  Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options Zacks
Mar-19-19 10:14PM  Aurinia Pharmaceuticals Inc (AUPH) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:14PM  Aurinia: 4Q Earnings Snapshot Associated Press
04:02PM  Aurinia Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights Business Wire
02:30PM  Aurinia Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
Mar-14-19 07:00AM  Aurinia Recognizes World Kidney Day and National Kidney Month with New Activities Focused on Raising Awareness for Kidney Disease Business Wire
Mar-12-19 10:30AM  Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for Zacks
Mar-07-19 04:05PM  Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2018 Financial Results on March 19, 2019 Business Wire
Feb-27-19 11:39AM  After Patent News, Aurinia Pharmaceuticals Still Has More to Prove InvestorPlace
06:30AM  Aurinia Closes At-The-Market Facility Business Wire
Feb-26-19 01:28PM  Big Pharma faces the Senate in drug price hearings Yahoo Finance Video
Feb-25-19 04:16PM  Here's Why Aurinia Pharmaceuticals' Stock Jumped Today Motley Fool +16.32%
07:00AM  Aurinia Receives Notice of Allowance from the US Patent and Trademark Office for Claims Directed to Its Novel Voclosporin Dosing Protocol for Lupus Nephritis Business Wire
Feb-20-19 04:01PM  Aurinia to Present at the 8th Annual SVB Leerink Global Healthcare Conference New York City Business Wire
Jan-30-19 02:33PM  Is Aurinia Pharmaceuticals a Buy? Motley Fool
08:10AM  Factors of Influence in 2019, Key Indicators and Opportunity within Leidos, Nomad Foods, Huron Consulting Group, Casella Waste, The Medicines, and Aurinia Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire
Jan-22-19 09:09AM  Aurinia's Dry Eye Syndrome Drug Produces Mixed Results In Mid-Stage Trial Benzinga -8.74%
07:00AM  Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® in a Phase 2 Head-to-Head Study for the Treatment of Dry Eye Syndrome Business Wire
Jan-21-19 04:49PM  Aurinia to Hold Conference Call and Webcast to Discuss Results of Phase 2 Head-to-Head Study of Voclosporin Ophthalmic Solution versus Restasis® for the Treatment of Dry Eye Syndrome Business Wire
08:45AM  Do Options Traders Know Something About Aurinia Pharmaceuticals (AUPH) Stock We Don't? Zacks
Jan-16-19 08:20AM  My Rx for How to Buy Aurinia Pharmaceuticals on Its Breakout
Dec-20-18 12:10PM  4 Pharma Stocks Getting a Boost on Thursday (12/20/18) ACCESSWIRE
Dec-19-18 08:00AM  Aurinia to Present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco Business Wire
Nov-30-18 05:18PM  Aurinia Establishes at-the-Market Facility Business Wire
Nov-27-18 08:00AM  Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-09-18 07:00AM  Aurinia to Participate in November Investor Conferences Business Wire
Nov-08-18 05:45PM  Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:39PM  Aurinia: 3Q Earnings Snapshot Associated Press
04:02PM  Aurinia Reports Third Quarter Financial Results, Clinical Highlights and Corporate Development Business Wire
Oct-25-18 07:00AM  Aurinia Pharmaceuticals to Release Third Quarter Financial Results and General Business Updates on November 8, 2018 Business Wire +5.71%
Oct-16-18 08:55AM  New Research: Key Drivers of Growth for Haverty Furniture Companies, BLACKLINE INC, MagnaChip Semiconductor, Kinross Gold, Aurinia Pharmaceuticals, and NEXEO SOLUTIONS Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Oct-03-18 05:49PM  Here's What Pushed Aurinia Pharmaceuticals Inc. Up 16.8% in September Motley Fool
Sep-28-18 08:31AM  Aurinia Pharmaceuticals (AUPH) in Focus: Stock Moves 6.7% Higher Zacks
Sep-26-18 08:25AM  The Daily Biotech Pulse: Verastem's Chinese Duvelisib Licensing Deal, Aldeyra's Positive Dry Eye Disease Drug Trial Benzinga
Sep-25-18 04:01PM  Aurinia Completes Enrollment of AURORA, its Phase 3 Clinical Trial for the Treatment of Lupus Nephritis Business Wire
Sep-19-18 04:01PM  Aurinia to Participate in Upcoming Investor Conferences Business Wire
Aug-28-18 07:00AM  Aurinia Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018 Business Wire
Aug-17-18 07:35AM  Investor Expectations to Drive Momentum within Natural Resource Partners LP, Insmed, MagnaChip Semiconductor, Changyou, Pain Therapeutics, and Aurinia Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire
Aug-09-18 05:35PM  Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:31PM  Aurinia: 2Q Earnings Snapshot Associated Press
04:02PM  Aurinia Reports Second Quarter Financial Results and Operational Highlights Business Wire
12:44PM  Aurinia Pharmaceuticals Incs (TSE:AUP) Shift From Loss To Profit Simply Wall St.
Jul-30-18 04:20PM  Aurinia Pharmaceuticals to Release Second Quarter 2018 Financial Results on August 9, 2018 Business Wire -5.01%
Jul-20-18 06:00AM  5 Favorite Biotech Bets Investopedia
Jul-14-18 03:47PM  Here's Why Aurinia Pharmaceuticals Inc. Gained 32.2% in the First Half of 2018 Motley Fool
Jul-13-18 10:36AM  Aurinia Pharmaceuticals Has Lots of Upside Potential InvestorPlace
Jul-12-18 08:37AM  Benzinga's Daily Biotech Pulse: AbbVie Files sNDA For Leukemia Drug, AcelRx Offering, Aurinia Starts Mid-Stage Trial Benzinga
Jul-11-18 04:01PM  Aurinia Initiates Phase 2 Clinical Trial for Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome Business Wire
Jun-26-18 07:10AM  Free Technical Reports on Array BioPharma and Three Additional Biotech Equities ACCESSWIRE
Jun-25-18 07:00AM  Aurinia Initiates Clinical Trials Broadening the Development of Voclosporin Business Wire
Jun-22-18 04:30PM  Aurinia Announces Results of Annual General Meeting Business Wire
Jun-14-18 12:37PM  Breakeven On The Horizon For Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Simply Wall St.
Jun-12-18 11:17AM  Here's Why Aurinia Pharmaceuticals Inc. Jumped 11% in May Motley Fool
Jun-01-18 08:20AM  Factors of Influence in 2018, Key Indicators and Opportunity within Shinhan Financial Group, Aurinia Pharmaceuticals, Delphi Technologies, Green Plains Partners LP, Sprague Resources LP, and CRH New Research Emphasizes Economic Growth GlobeNewswire
May-16-18 07:05AM  Free Stock Performance Review on Array BioPharma and Three More Biotech Industry ACCESSWIRE
May-14-18 01:34PM  Here's Why Aurinia Pharmaceuticals Inc. Is Surging Today Motley Fool +11.25%
May-10-18 09:15PM  Will Aurinia Pharmaceuticals Incs (NASDAQ:AUPH) Earnings Grow In The Years Ahead? Simply Wall St.
04:59PM  Aurinia: 1Q Earnings Snapshot Associated Press
04:02PM  Aurinia Reports First Quarter Financial Results and Operational Highlights Business Wire
08:00AM  Aurinia Pharmaceuticals Recognizes World Lupus DayTM with Activities Focused on Raising Awareness of Lupus Nephritis Business Wire
May-01-18 04:23PM  Aurinia Pharmaceuticals to Release First Quarter 2018 Financial Results on May 10, 2018 Business Wire
Apr-25-18 04:01PM  Aurinia to Present at the Bloom Burton & Co. Healthcare Investor Conference on May 3, 2018 Business Wire
Apr-22-18 09:32AM  Don't Get Greedy With Aurinia Pharmaceuticals Stock Motley Fool
Apr-13-18 12:02PM  April Growth Opportunities Espial Group And More Simply Wall St.
Apr-09-18 07:45AM  New Research Coverage Highlights SINOPEC Shangai Petrochemical, Aurinia Pharmaceuticals, Valeant Pharmaceuticals International, NTT DOCOMO, Southern Missouri, and KNOT Offshore Partners LP Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Apr-02-18 04:01PM  Aurinia Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018 Business Wire
Mar-21-18 07:30AM  Blog Exposure - Aclaris Therapeutics Shares Positive Update on Phase-2 Results after a 3-Month Follow-Up of A-101 45% Topical Solution ACCESSWIRE
Mar-20-18 08:10AM  Aurinia Pharmaceuticals, Voclosporin Updates, Analysts Target Price and 2018 Outlook ACCESSWIRE -6.16%
Mar-16-18 10:54AM  Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Is Expected To Breakeven Simply Wall St. +6.53%
Mar-15-18 04:55PM  Aurinia reports 4Q loss Associated Press
04:02PM  Aurinia Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights Business Wire
12:15PM  Aurinia Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
Mar-13-18 08:00AM  Consolidated Research: 2018 Summary Expectations for B Communications, Student Transportation, Aurinia Pharmaceuticals, Grifols, S.A., NEXEO SOLUTIONS, and ASML Holding N.V.  Fundamental Analysis, Key Performance Indications GlobeNewswire
Feb-28-18 04:02PM  Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2017 Financial Results on March 15, 2018 Business Wire
Feb-22-18 04:07PM  Aurinia Enhances Research, Development, and Scientific Expertise with the Appointment of Michael Hayden to its Board of Directors Business Wire
07:54AM  Could Aurinia Pharmaceuticals Be a Millionaire-Maker Stock? Motley Fool
Feb-20-18 04:01PM  Aurinia Named Company of the Year by LifeSciences BC Business Wire
Feb-14-18 08:00AM  Aurinia Pharmaceuticals Launches New Lupus Nephritis Disease Awareness Program Business Wire
Feb-10-18 11:02AM  February Growth Stocks To Look Out For Simply Wall St.
Feb-08-18 08:00AM  Aurinia Enhances Commercial and Business Development Expertise with the Appointment of Joseph P. Hagan to its Board of Directors Business Wire
Feb-06-18 08:00AM  Aurinia to Present at Leerink Partners 7th Annual Global Healthcare Conference Business Wire +6.39%
Jan-19-18 11:28AM  A Breakout in Aurinia Pharmaceuticals Inc May Be Imminent InvestorPlace
Jan-05-18 02:12PM  Here's What Knocked Aurinia Pharmaceuticals Inc. Down 16.1% in December Motley Fool
08:10AM  Todays Research Reports on Trending Tickers: Aurinia Pharmaceuticals Inc. and INSYS Therapeutics, Inc. ACCESSWIRE
Jan-04-18 05:16PM  Aurinia Pharmaceuticals Inc (AUPH) Shares Dip on New Shelf Registration SmarterAnalyst +5.42%
04:37PM  Aurinia Pharmaceuticals Files New Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus Business Wire
Jan-03-18 06:32AM  3 Stocks Wall Street Hasn't Heard of Yet Motley Fool
Dec-25-17 09:22AM  Aurinia Pharmaceuticals, Inc. :AUPH-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017 Capital Cube
Dec-19-17 07:34AM  Is Aurinia Pharmaceuticals a Buy? Motley Fool
Dec-11-17 06:16PM  Aurinia Pharmaceuticals Inc (AUPH) to Enter NASDAQ Biotech Index SmarterAnalyst
04:02PM  Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index Business Wire
Nov-21-17 11:02AM  Growth Stocks Investors Love Simply Wall St.
Nov-17-17 08:53AM  Aurinia Has Canaccord Captivated with Voclosporin Prospects SmarterAnalyst
Nov-16-17 09:24AM  Where Will Aurinia Pharmaceuticals Be in 5 Years? Motley Fool
08:20AM  Todays Research Reports on Trending Tickers: Achillion Pharmaceuticals and Aurinia Pharmaceuticals ACCESSWIRE
05:14AM  Aurinia reports 3Q loss Associated Press
Nov-15-17 02:58PM  H.C. Wainwright Likes Aurinia Pharmaceuticals Opportunity at Hand in the Lupus Nephritis Market SmarterAnalyst -6.37%
Nov-14-17 04:00PM  Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights Business Wire
01:15PM  What Does Aurinia Pharmaceuticals Incs (TSX:AUP) Share Price Indicate? Simply Wall St.
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic drugs for the treatment of autoimmune diseases in Canada, the United States, China, and Switzerland. The company is developing voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. It has a sales agreement with Cantor Fitzgerald & Co.; and a manufacturing collaboration and services agreement with Lonza Ltd. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.